Catalina Capital Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Buy
+1,929
New +$223K 0.14% 131
2025
Q2
Sell
-2,570
Closed -$231K 193
2025
Q1
$231K Sell
2,570
-7,753
-75% -$724K 0.15% 140
2024
Q4
$1.03M Buy
10,323
+678
+7% +$69.9K 0.34% 55
2024
Q3
$1.1M Sell
9,645
-216
-2% -$25.7K 0.37% 55
2024
Q2
$1.22M Buy
9,861
+1,653
+20% +$213K 0.46% 47
2024
Q1
$1.08M Buy
8,208
+5,066
+161% +$624K 0.45% 49
2023
Q4
$343K Buy
+3,142
New +$326K 0.23% 83

Other funds holding MRK

Catalina Capital Group's MRK Position: Q1 2026 in Review

Catalina Capital Group opened a new position in Merck (MRK) in Q1 2026: 1,929 shares worth $232K. The stake represents 0.14% of the portfolio and ranks #131 among its holdings. This is a return to the name: Catalina Capital Group previously reported a position in MRK as recently as Q1 2025.

Catalina Capital Group first reported a position in MRK in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.22M in Q2 2024. 3,796 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Catalina Capital Group held 1,929 shares of Merck worth $232K as of Q1 2026.
  • Merck was a new Catalina Capital Group position in Q1 2026.
  • Merck made up 0.14% of Catalina Capital Group's portfolio in Q1 2026, its #131 holding.
  • Catalina Capital Group first reported a position in Merck in Q4 2023 and has held it in 7 quarters since.
  • Catalina Capital Group's Merck position peaked at $1.22M in Q2 2024.
  • 3,796 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Catalina Capital Group's 13F filing for Q1 2026, filed 23 Apr 2026.